跳至主要内容
临床试验/CTRI/2022/09/045983
CTRI/2022/09/045983尚未招募未知

Early identification of metabolic function derangements such as diabetes, liver, renal issues by Humorsâ?? smart breath analyzer and its validation as a screening tool among diseased and healthy controls

Humors Tech Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Participant must either be a completely healthy individual as confirmed by blood examination or a known case of diseases in focus such as diabetes, kidney issue, liver issue, lung issue and lipid issue with relevant diagnostics reports tested within 15 days of participation in the study.
  • a. Patients that are known case of Diabetes tested for FBS or RBS within 15 days of participation
  • b. Patients that are known case of kidney related disease tested for RFT within 15 days of participation
  • c. Patients that are known case of liver related disease tested for LFT within 15 days of participation
  • d. Patients that are known case of lung related disease tested by spirometry within 15 days of participation
  • e. Patients that are known case of lipid related disease tested for lipid profile within 15 days of participation.
  • 2. All genders, ethnicity
  • 3. Age Group: 18 to 75years
  • 4. Participant who has given informed consent for participating in this study
  • 5. Participant must be fully vaccinated for COVID
  • 6. Participant must use smart breath analyzer at fasting condition. If not fasting, there should be a minimum gap of 1 hour between consuming water and testing, and 3-4 hours between consuming food and testing.

排除标准

  • 1. Individual less than 18 or above 75years of age
  • 2. Pregnant and lactating females
  • 3. Known case of ongoing illness such as
  • d. Cough, Fever
  • f. Chickenpox
  • g. Influenza
  • 4. Individual who has not given informed consent for this study

研究者

发起方
Humors Tech Pvt Ltd

相似试验